PortfoliosLab logoPortfoliosLab logo
VYNE vs. VGSTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

VYNE vs. VGSTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VYNE Therapeutics Inc. (VYNE) and Vanguard STAR Fund (VGSTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VYNE achieves a 13.08% return, which is significantly higher than VGSTX's 6.45% return.


VYNE

1D
-2.96%
1M
-0.00%
YTD
13.08%
6M
75.07%
1Y
-34.25%
3Y*
-52.34%
5Y*
-60.58%
10Y*

VGSTX

1D
0.10%
1M
3.50%
YTD
6.45%
6M
7.04%
1Y
18.40%
3Y*
14.88%
5Y*
6.81%
10Y*
9.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VYNE vs. VGSTX - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
VYNE
VYNE Therapeutics Inc.
13.08%-82.68%43.78%-13.70%-85.29%-83.86%-65.95%12.62%-85.65%
VGSTX
Vanguard STAR Fund
6.45%15.88%13.69%17.14%-18.05%9.65%21.45%22.21%-9.06%

Correlation

The correlation between VYNE and VGSTX is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jan 26, 2018

0.26

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VYNE vs. VGSTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VYNE
VYNE Risk / Return Rank: 3737
Overall Rank
VYNE Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
VYNE Sortino Ratio Rank: 4545
Sortino Ratio Rank
VYNE Omega Ratio Rank: 5353
Omega Ratio Rank
VYNE Calmar Ratio Rank: 2727
Calmar Ratio Rank
VYNE Martin Ratio Rank: 3232
Martin Ratio Rank

VGSTX
VGSTX Risk / Return Rank: 5656
Overall Rank
VGSTX Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
VGSTX Sortino Ratio Rank: 5656
Sortino Ratio Rank
VGSTX Omega Ratio Rank: 5555
Omega Ratio Rank
VGSTX Calmar Ratio Rank: 5252
Calmar Ratio Rank
VGSTX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VYNE vs. VGSTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VYNE Therapeutics Inc. (VYNE) and Vanguard STAR Fund (VGSTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VYNEVGSTXDifference

Sharpe ratio

Return per unit of total volatility

-0.30

2.21

-2.51

Sortino ratio

Return per unit of downside risk

0.61

3.16

-2.55

Omega ratio

Gain probability vs. loss probability

1.13

1.41

-0.28

Calmar ratio

Return relative to maximum drawdown

-0.41

2.77

-3.18

Martin ratio

Return relative to average drawdown

-0.51

12.06

-12.57

VYNE vs. VGSTX - Sharpe Ratio Comparison

The current VYNE Sharpe Ratio is -0.30, which is lower than the VGSTX Sharpe Ratio of 2.21. The chart below compares the historical Sharpe Ratios of VYNE and VGSTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


VYNEVGSTXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.30

2.21

-2.51

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.58

0.58

-1.16

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.82

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.60

0.81

-1.41

Drawdowns

VYNE vs. VGSTX - Drawdown Comparison

The maximum VYNE drawdown since its inception was -99.99%, which is greater than VGSTX's maximum drawdown of -38.62%. Use the drawdown chart below to compare losses from any high point for VYNE and VGSTX.


Loading charts...

Drawdown Indicators


VYNEVGSTXDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-38.62%

-61.37%

Max Drawdown (1Y)

Largest decline over 1 year

-83.79%

-6.76%

-77.03%

Max Drawdown (3Y)

Largest decline over 3 years

-95.23%

-11.77%

-83.46%

Max Drawdown (5Y)

Largest decline over 5 years

-99.61%

-25.55%

-74.06%

Max Drawdown (10Y)

Largest decline over 10 years

-25.55%

Current Drawdown

Current decline from peak

-99.98%

0.00%

-99.98%

Average Drawdown

Average peak-to-trough decline

-93.08%

-4.03%

-89.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

67.22%

1.55%

+65.67%

Volatility

VYNE vs. VGSTX - Volatility Comparison

VYNE Therapeutics Inc. (VYNE) has a higher volatility of 5.19% compared to Vanguard STAR Fund (VGSTX) at 2.46%. This indicates that VYNE's price experiences larger fluctuations and is considered to be riskier than VGSTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VYNEVGSTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.19%

2.46%

+2.73%

Volatility (6M)

Calculated over the trailing 6-month period

46.93%

6.69%

+40.24%

Volatility (1Y)

Calculated over the trailing 1-year period

115.78%

8.47%

+107.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

105.07%

11.82%

+93.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

103.33%

11.83%

+91.50%

Dividends

VYNE vs. VGSTX - Dividend Comparison

VYNE has not paid dividends to shareholders, while VGSTX's dividend yield for the trailing twelve months is around 8.57%.


PositionTTM20252024202320222021202020192018201720162015
VGSTX
Vanguard STAR Fund
8.57%9.13%10.67%5.35%8.34%6.70%6.68%6.07%6.90%3.32%4.77%5.62%
VYNE
VYNE Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


VYNE and VGSTX have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VYNE has higher volatility (5.19%) compared to VGSTX (2.46%). In terms of maximum drawdown, VYNE dropped -99.99% vs VGSTX's -38.62%.

VGSTX currently has the higher Sharpe Ratio (2.21 vs -0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VYNE and VGSTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer